May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
PROTEASOME ACTIVITY IS REQUIRED FOR LENS CELL DIFFERENTIATION
Author Affiliations & Notes
  • W. Guo
    Human Nutrition Res Ctr, Tufts University, Boston, MA
  • F. Shang
    Human Nutrition Res Ctr, Tufts University, Boston, MA
  • Q. Liu
    Human Nutrition Res Ctr, Tufts University, Boston, MA
  • L. Urim
    Department of Ophthalmology, New England Medical Center, Boston, MA
  • A. Taylor
    Human Nutrition Res Ctr, Tufts University, Boston, MA
  • Footnotes
    Commercial Relationships  W. Guo, None; F. Shang, None; Q. Liu, None; L. Urim, None; A. Taylor, None.
  • Footnotes
    Support  EY13250, EY11717, EY13078
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 2636. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      W. Guo, F. Shang, Q. Liu, L. Urim, A. Taylor; PROTEASOME ACTIVITY IS REQUIRED FOR LENS CELL DIFFERENTIATION . Invest. Ophthalmol. Vis. Sci. 2004;45(13):2636.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To investigate the role of the ubiquitin–proteasome pathway in controlling lens cell proliferation and differentiation. Methods: bFGF–induced lens cell proliferation and differentiation was monitored in rat lens epithelial explants by BrdU incorporation, expression of crystallins and other differentiation markers. Lactacystin was used as a proteasome–specific inhibitor to study the role of proteasome in controlling the proliferation and differentiation process. Results: Explants treated with bFGF initially underwent enhanced proliferation as indicated by BrdU incorporation and multilayering of the epithelial cells, and then withdrawal from cell cycle as indicated by diminished BrdU incorporation. After 7 days treatment with bFGF, Lens epithelial explants displayed characteristics of lens fibers, including expression of large quantities of crystallins, MIP26, CP49 and filensin. Addition of the lactacystin to the medium at the same time as bFGF (Day 0) prohibited or delayed bFGF–induced cell proliferation and differentiation as indicated by reduced BrdU incorporation, decreased expression of beta– and gamma–crystallins, MIP26, CP49 and filensin. If lactacystin was added to the medium at day 4 of bFGF treatment, when the cells stopped proliferation, it still decreased the production of beta–crystallins and CP49. Conclusions: The data show that the ubiquitin–proteasome pathway is required for lens cell proliferation and differentiation. It appears that the ubiquitin–proteasome pathway is not only required at the proliferative stages of the differentiation process, it is also required for the expression of fiber–specific proteins. Disruption of the function of this proteolytic pathway may cause abnormal lens development, such as delayed differentiation and maturation of lens fibers.

Keywords: proliferation • proteolysis • cataract 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×